GlaxoSmithKline comes under renewed activist pressure as Bluebell builds stake

Sep. 22, 2021 1:46 PM ETGSK plc (GSK)PFEBy: Dulan Lokuwithana, SA News Editor10 Comments

Four Injured In Explosion At GlaxoSmithKline Factory
Jeff J Mitchell/Getty Images News

  • Activist hedge fund Bluebell Capital Partners has built a small stake in GlaxoSmithKline (NYSE:GSK), demanding several changes at the pharma group, including calls for CEO Emma Walmsley to reapply for her job, according to

Recommended For You

Comments (10)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.